PRLD · Prelude Therapeutics Inc · Documents
$3.88
+0.18 (+4.86%)
At close · Oct 27
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Market Cap
$295.27M
Shares
79.80M
Volume · Oct 27
277.22K
Avg daily vol (3M)
518.04K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-12-03 | 2021-11-30 | |
| 10-Q | — | 2021-11-12 | 2021-09-30 | |
| S-3 | — | 2021-11-12 | — | |
| 8-K | — | 2021-11-12 | 2021-11-05 | |
| 8-K | — | 2021-09-17 | 2021-09-16 | |
| 10-Q | — | 2021-08-12 | 2021-06-30 | |
| 8-K | — | 2021-08-12 | — | |
| 8-K | — | 2021-07-19 | 2021-07-15 | |
| 8-K | — | 2021-06-22 | 2021-06-18 | |
| 8-K | — | 2021-05-12 | — | |
| 10-Q | — | 2021-05-11 | 2021-03-31 | |
| 8-K | — | 2021-05-11 | — | |
| DEFA14A | — | 2021-04-29 | — | |
| DEF 14A | — | 2021-04-29 | 2021-06-18 | |
| 8-K | — | 2021-03-17 | — | |
| 8-K | — | 2021-03-16 | — | |
| 10-K | — | 2021-03-16 | 2020-12-31 | |
| 8-K | — | 2021-03-08 | 2021-03-02 | |
| 8-K | — | 2021-01-28 | 2021-01-22 | |
| 8-K | — | 2021-01-04 | — | |
| S-1 | — | 2021-01-04 | — | |
| 8-K | — | 2020-11-10 | — | |
| 10-Q | — | 2020-11-10 | 2020-09-30 | |
| 8-K | — | 2020-11-04 | 2020-11-01 | |
| S-1/A | — | 2020-09-21 | — | |
| S-1/A | — | 2020-09-16 | — | |
| S-1 | — | 2020-09-04 | — |
Showing 101–127 of 127 filings